Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-31

Clinical Trial Update: Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating circadian-focused light therapy for progressive multiple sclerosis is currently enrolling by invitation, sponsored by the University …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Circadian Focused Light Therapy

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Progressive Multiple Sclerosis | Phase 1 | Status: ENROLLING_BY_INVITATION